Lastly, among nine patients with EGFR-positive NSCLC receiving a second-generation EGFR-targeted CAR-T, one had a radiological response that persisted for more than 1 year, with squamous NSCLC, and two experienced disease stabilization for 2 months. Here, EGFR is linked to non-small cell lung carcinoma.